Heart Failure: Update on Therapeutic Options

نویسنده

  • David T. Nash
چکیده

Heart failure statistics are daunting: 550,000 new cases each year, a 1-year mortality rate of nearly 20%, and annual direct and indirect costs that total $24.3 billion.1 The diverse etiology of heart failure and the complex, progressive course of the disease can make treatment decisions daunting as well. Here I discuss current recommendations for heart failure management, as well as the clinical implications of the results of recent studies. RISK FACTORS Among the 5143 participants in the original Framingham Heart and Offspring studies, the most common risk factor for heart failure was hypertension. Of those study participants in whom heart failure developed, 91% were hypertensive.2 Among hypertensive men and women in these studies, myocardial infarction (MI), diabetes, left ventricular hypertrophy, and valvular heart disease were cofactors that were associated with an increased risk of heart failure. MI was a particularly common cofactor in this group; 52% of the men with heart failure and 34% of the women had a history of MI.2PATHOPHYSIOLOGY The pathophysiology of heart failure involves both hemodynamic and neurohormonal abnormalities, although the interactions between them are incompletely understood. Survival benefits that result from drug-induced decreases in neurohormonal activity underscore the role of increased neurohormonal activity in chronic heart failure. Impaired left ventricular function activates neuroendocrine compensatory mechanisms, both vasoconstrictive and vasodilative. The primary vasoconstrictive systems are the sympathetic nervous system and the reninangiotensin system. Increased plasma levels of norepinephrine, which reflect sympathetic nervous system activity, have been correlated directly with disease severity and mortality in heart failure.3 Activation of the renin-angiotensin system increases systemic vascular resistance and has also been correlated with disease progression. DIAGNOSIS The history and physical findings often point to heart failure. Common presenting symptoms in patients with left ventricular dysfunction are:

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Adult Patient with Eisenmenger Syndrome: A Medical Update After Dana Point Part I: Epidemiology, Clinical Aspects and Diagnostic Options

Eisenmenger syndrome is the most severe form of pulmonary arterial hypertension and arises on the basis of congenital heart disease with a systemic-to-pulmonary shunt. Due to the chronic slow progressive hypoxemia with central cyanosis, adult patients with the Eisenmenger syndrome suffer from a complex and multisystemic disorder including coagulation disorders (bleeding complications and parado...

متن کامل

Fetal cardiac interventions: an update of therapeutic options

OBJECTIVE This article aims to present updated therapeutic options for fetal congenital heart diseases. METHODS Data source for the present study was based on comprehensive literature retrieval on fetal cardiac interventions in terms of indications, technical approaches and clinical outcomes. RESULTS About 5% of fetal congenital heart diseases are critical and timely intrauterine interventi...

متن کامل

The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects

Eisenmenger syndrome is the most severe form of pulmonary arterial hypertension and arises on the basis of congenital heart disease with a systemic-to-pulmonary shunt. Due to the chronic slow progressive hypoxemia with central cyanosis, adult patients with the Eisenmenger syndrome suffer from a complex and multisystemic disorder including coagulation disorders (bleeding complications and parado...

متن کامل

The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part II: Medical Treatment - Study Results

Eisenmenger syndrome is the most severe form of pulmonary arterial hypertension and arises on the basis of congenital heart disease with a systemic-to-pulmonary shunt. Due to the chronic slow progressive hypoxemia with central cyanosis, adult patients with the Eisenmenger syndrome suffer from a complex and multisystemic disorder including coagulation disorders (bleeding complications and parado...

متن کامل

Heart Failure: A Class Review of Pharmacotherapy.

A recent guideline update for the treatment of heart failure has created the need for a new look at the medication classes and trials related to the disease. The authors focus on pharmacological options available for treating the problem.

متن کامل

New therapeutic options in congestive heart failure: Part I.

New Therapeutic Options in Congestive Heart Failure: Part I Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2002 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/01.CIR.0000014763.63528.9D 2002;105:2099-2106 Circulation. http://circ.ahajournals.org/content/105/17/2099...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2017